PH-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: IS CHEMOTHERAPY NECESSARY?

被引：0
|
作者：
Foa, Robin [1 ]
机构：
[1] Sapienza Univ, Hematol, Dept Biomed Sci & Hematol, Rome, Italy
来源：
LEUKEMIA RESEARCH | 2017年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SP-10
引用
收藏
页码：S4 / S5
页数：2
相关论文
共 50 条
  • [41] DIFFERENCES BETWEEN BLASTIC CHRONIC MYELOID-LEUKEMIA AND PH-POSITIVE ACUTE-LEUKEMIA
    BERGER, R
    LEUKEMIA & LYMPHOMA, 1993, 11 : 235 - 237
  • [42] Ph-negative acute lymphocytic leukemia occurring after interferon therapy for Ph-positive chronic myelocytic leukemia
    Zhang, XW
    Ji, LX
    Liu, SH
    Wang, JX
    LEUKEMIA RESEARCH, 2003, 27 (04) : 367 - 369
  • [43] Treatment of Philadelphia chromosome (Ph)-positive acute lymphoblastic leukemia (ALL) with concurrent chemotherapy and imatinib mesylate
    Ribera, JM
    Oriol, A
    Gonzalez, M
    Vidriales, MB
    Xicoy, B
    Grau, J
    Esteve, J
    Brunet, S
    Del Potro, E
    Moreno, MJ
    Tormo, M
    Martin-Reina, MV
    Deben, G
    Parody, R
    Lahuerta, UJ
    San Miguel, JF
    BLOOD, 2004, 104 (11) : 203B - 204B
  • [44] Autologous HSCT for Ph-Positive Adult Acute Lymphoblastic Leukemia: A Curative Option in the Era of Tyrosine Kinase Inhibitors? an Analysis From the Acute Leukemia Working Party of the EBMT
    Giebel, Sebastian
    Labopin, Myriam
    Gorin, Norbert Claude
    Caillot, Denis
    Leguay, Thibaut
    Schaap, Nicolaas
    Michallet, Mauricette
    Socie, Gerard
    Mohty, Mohamad
    BLOOD, 2012, 120 (21)
  • [45] Blinatumomab with Tyrosine Kinase Inhibitor for Ph-Positive B-Acute Lymphoblastic Leukemia (B-ALL): Multicenter Retrospective Review
    Aleid, Manar
    Alrajhi, Abdullah
    Alwadi, Mohammmad
    Alsugair, Ali
    Alshehri, Hassan
    Tailor, Imran K.
    Hanbali, Amr
    Alfraih, Feras Abdulaziz
    Alhayli, Saud
    Alahmari, Ali
    Albabtain, Abdulwahab
    Alotaibi, Ahmad S.
    Alnoamani, Mohammed S.
    Alshehry, Nawal F.
    Motabi, Ibraheem H.
    Alzahrani, Hazza A.
    Marei, Mohammed A.
    Saad, Ayman
    Aljurf, Mahmoud
    Elfakih, Riad
    Alhumaid, Muhned
    Alfayez, Mansour
    BLOOD, 2023, 142
  • [46] MINIMAL RESIDUAL DISEASE IN PATIENTS WITH PH-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA BEFORE AND AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    MARTIN, H
    ATTA, J
    BRUECHER, J
    CLAUDE, R
    ELSNER, S
    HOELZER, D
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1065 - 1065
  • [47] Successful Molecular Remission with Ponatinib in a 3-year-old Girl with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph-Positive ALL)
    Tanimura, Kazuki
    Yamasaki, Kai
    Okuhiro, Yuki
    Hira, Kouta
    Nitani, Chika
    Okada, Keiko
    Fujisaki, Hiroyuki
    Matsumoto, Kana
    Hara, Junichi
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S33 - S33
  • [48] Identification of a new mechanism of resistance to imatinib and dasatinib in PH-positive acute lymphoblastic leukemia: Overexpression of aberrantly spliced oncogenic Ikaros informs
    Iacobucci, I.
    Soverini, S.
    Paolini, S.
    Piccaluga, P. P.
    Rondori, M.
    Ottaviani, E.
    Amabile, M.
    Poerio, A.
    Castagnetti, F.
    Giannoulia, P.
    Colarossi, S.
    Gnari, A.
    Cillori, D.
    Saglio, G.
    Pane, F.
    Rosti, G.
    Baccarani, M.
    Martinelli, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 2 - 3
  • [49] Excellent results of allogeneic hematopoietic stem cell transplantation for relapsed/refractory ph-positive b-cell acute lymphoblastic leukemia
    Song, Y.
    Li, Z.
    Zhao, Y.
    Yuan, E.
    Qin, Q.
    Gao, K.
    Wang, Q.
    Wu, T.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 223 - 224
  • [50] BASOPHIL DIFFERENTIATION IN PH-POSITIVE BLAST CELL LEUKEMIA
    LAWLOR, E
    MCCANN, SR
    WILLOUGHBY, R
    DUNNE, J
    TEMPERLEY, IJ
    BRITISH JOURNAL OF HAEMATOLOGY, 1983, 54 (01) : 157 - 160
12345